miR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor

Tumor Biology

Volumn 35, Issue 9, 2014, Pages 9131-9138

  Liu, Sheng ^a   Cui, Juan ^b   Liao, Guoqing ^a   Zhang, Yi ^a   Ye, Ke ^a   Lu, Tailiang ^a   Qi, Jing ^a   Wan, Guohui ^c,d  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Department of Neurosurgery The First Affiliated Hospital of Luohe Medical College (Luohe Central Hospital)   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

EMT; GIST; miR 137; Twist

Indexed keywords

CYTOKERATIN; MICRORNA; MICRORNA 137; NERVE CELL ADHESION MOLECULE; REGULATOR PROTEIN; TRANSCRIPTION FACTOR TWIST; TWIST1 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; 3' UNTRANSLATED REGION; CADHERIN; KERATIN; MIRN137 MICRORNA, HUMAN; NUCLEAR PROTEIN; TWIST1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER TISSUE; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; G1 PHASE CELL CYCLE CHECKPOINT; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; 3' UNTRANSLATED REGION; CELL CYCLE; CELL MOTION; FLUORESCENCE MICROSCOPY; GASTROINTESTINAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; RNA INTERFERENCE; SEQUENCE HOMOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CADHERINS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINS; MICRORNAS; MICROSCOPY, FLUORESCENCE; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEQUENCE HOMOLOGY, NUCLEIC ACID; TWIST TRANSCRIPTION FACTOR; VIMENTIN;

EID: 84919783018     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2177-5     Document Type: Article

References (45)

1. Datar M, Khanna R. Inpatient burden of gastrointestinal stromal tumors in the United States. J Gastroint Oncol. 2012;3:335–41.
2. Patel S. Exploring novel therapeutic targets in gist: focus on the pi3k/akt/mtor pathway. Curr Oncol Rep. 2013;15:386–95.
3. Miettinen M, Lasota J. Gastrointestinal stromal tumors—definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch Int J Pathol. 2001;438:1–12.
4. Rubin BP, Heinrich MC, Corless CL. Gastrointestinal stromal tumour. Lancet. 2007;369:1731–41.
5. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466–78.
6. Lennartsson J, Ronnstrand L. The stem cell factor receptor/c-Kit as a drug target in cancer. Curr Cancer Drug Targets. 2006;6:65–75.
7. Krajinovic K, Germer CT, Agaimy A, Wunsch PH, Isbert C. Outcome after resection of one hundred gastrointestinal stromal tumors. Dig Surg. 2010;27:313–9.
8. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004;101:2999–3004.
9. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103:2257–61.
10. Zhou Y, Wan G, Spizzo R, Ivan C, Mathur R, Hu X, et al. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase. Mol Oncol. 2014;8:83–92.
11. Wan G, Zhang X, Langley RR, Liu Y, Hu X, Han C, et al. DNA-damage-induced nuclear export of precursor microRNAs is regulated by the ATM-AKT pathway. Cell Rep. 2013;3:2100–12.
12. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–33.
13. Gits CM, van Kuijk PF, Jonkers MB, Boersma AW, van Ijcken WF, Wozniak A, et al. Mir-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours. Br J Cancer. 2013;109:1625–35.
14. Yamamoto H, Kohashi K, Fujita A, Oda Y. Fascin-1 overexpression and miR-133b downregulation in the progression of gastrointestinal stromal tumor. Mod Pathol Off J U S Can Acad Pathol Inc. 2013;26:563–71.
15. Niinuma T, Suzuki H, Nojima M, Nosho K, Yamamoto H, Takamaru H, et al. Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res. 2012;72:1126–36.
16. Kim WK, Park M, Kim YK, Tae YK, Yang HK, Lee JM, et al. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation. Clin Cancer Res Off J Am Assoc Cancer Res. 2011;17:7584–94.
17. Fan R, Zhong J, Zheng S, Wang Z, Xu Y, Li S, et al. MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 2013.
18. Liu S, Liao G, Ding J, Ye K, Zhang Y, Zeng L, et al. Dysregulated expression of Snail and E-cadherin correlates with gastrointestinal stromal tumor metastasis. Eur J Cancer Prev. 2014.
19. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–90.
20. Tsai JH, Yang J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013;27:2192–206.
21. Gao D, Vahdat LT, Wong S, Chang JC, Mittal V. Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Res. 2012;72:4883–9.
22. Zhu B, Liao G, Liu S, Huang B, Wu S, Zhou J, et al. Characteristics and establishment of cell lines from human gastrointestinal stromal tumors. Zhong nan da xue xue bao Yi xue ban J Cent South Univ Med Sci. 2010;35:1138–44.
23. Wan G, Cheuk WK, Chan KM. Differential regulation of zebrafish metallothionein-II (zMT-II) gene transcription in ZFL and SJD cell lines by metal ions. Aquat Toxicol. 2009;91:33–43.
24. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117:927–39.
25. Scheel C, Weinberg RA. Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells? Int J Cancer J Int Cancer. 2011;129:2310–4.
26. Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annu Rev Med. 2009;60:167–79.
27. Song DW, Ryu JY, Kim JO, Kwon EJ, Kim do H. The miR-19a/b family positively regulates cardiomyocyte hypertrophy by targeting atrogin-1 and MuRF-1. Biochem J. 2014;457:151–62.
28. Kelly L, Bryan K, Kim SY, Janeway KA, Killian JK, Schildhaus HU, et al. Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST]. PLoS One. 2013;8:e64102.
29. Bemis LT, Chen R, Amato CM, Classen EH, Robinson SE, Coffey DG, et al. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res. 2008;68:1362–8.
30. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008;6:14.
31. Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, Boland CR, et al. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res. 2010;70:6609–18.
32. Chen Q, Chen X, Zhang M, Fan Q, Luo S, Cao X. miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42. Dig Dis Sci. 2011;56:2009–16.
33. Chen L, Wang X, Wang H, Li Y, Yan W, Han L, et al. miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2. Eur J Cancer. 2012;48:3104–11.
34. Zhao Y, Li Y, Lou G, Zhao L, Xu Z, Zhang Y, et al. MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells. PLoS One. 2012;7:e39102.
35. Althoff K, Beckers A, Odersky A, Mestdagh P, Koster J, Bray IM, et al. MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A. Int J Cancer J Int Cancer. 2013;133:1064–73.
36. Guo J, Xia B, Meng F, Lou G. miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1. Biochem Biophys Res Commun. 2013;441:357–63.
37. Tamim S, Vo DT, Uren PJ, Qiao M, Bindewald E, Kasprzak WK, et al. Genomic analyses reveal broad impact of miR-137 on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells. PLoS One. 2014;9:e85591.
38. Bier A, Giladi N, Kronfeld N, Lee HK, Cazacu S, Finniss S, et al. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Oncotarget. 2013;4:665–76.
39. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420–8.
40. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9:265–73.
41. Dave B, Mittal V, Tan NM, Chang JC. Epithelial-mesenchymal transition, cancer stem cells and treatment resistance. Breast Cancer Res BCR. 2012;14:202.
42. Fang X, Cai Y, Liu J, Wang Z, Wu Q, Zhang Z, et al. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal. Oncogene. 2011;30:4707–20.
43. Li L, Cserjesi P, Olson EN. Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis. Dev Biol. 1995;172:280–92.
44. Casas E, Kim J, Bendesky A, Ohno-Machado L, Wolfe CJ, Yang J. Snail2 is an essential mediator of twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res. 2011;71:245–54.
45. Eckert MA, Lwin TM, Chang AT, Kim J, Danis E, Ohno-Machado L, et al. Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell. 2011;19:372–86.